from Reuters: Health News https://reut.rs/2Hba7Rp
Friday, January 11, 2019
Lilly eyes more cancer deals, but wary of CAR-T, gene therapy
Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology this week, but it plans to remain on the sidelines when it comes to two of the hottest areas of drug development.
from Reuters: Health News https://reut.rs/2Hba7Rp
from Reuters: Health News https://reut.rs/2Hba7Rp
Subscribe to:
Post Comments (Atom)
-
(Reuters Health) - More than half of heart failure patients who visit the emergency room don't receive prompt follow-up care, and a Cana...
-
WEIGHT LOSS supplements could help overweight or obese patients with the diet plans. You could lose weight and avoid weight gain by adding...
-
A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for an temporary restraining order blocking sales of generic v...
No comments:
Post a Comment